Skip to main content

VAN ECK ASSOCIATES CORP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 869178 NEW YORK, NY

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$48,354,901
-$1,735,601 QoQ
Shares Held
62,584
-3.6% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

VAN ECK ASSOCIATES CORP holds $332,748,136 across 30 Biotechnology names. REGN ranks #2 (14.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
62,584 $48,354,901

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $48,354,901 62,584
2025-12-31 $50,090,502 64,895
2025-09-30 $31,778,375 56,518
2025-06-30 $29,672,475 56,519
2025-03-31 $35,026,619 55,227
2024-12-31 $41,694,811 58,533
2024-09-30 $61,114,887 58,136
2024-06-30 $56,118,695 53,394
2024-03-31 $53,263,233 55,339
2023-12-31 $56,506,543 64,337
2023-09-30 $46,767,170 56,828
2023-06-30 $43,266,885 60,215
2023-03-31 $48,289,545 58,770
2022-12-31 $37,158,899 51,503
2022-09-30 $45,917,318 66,656
2022-06-30 $37,552,123 63,526
2022-03-31 $44,039,571 63,056
2021-12-31 $41,236,992 65,298
2021-09-30 $36,620,046 60,511
2021-06-30 $36,640,223 65,600
2021-03-31 $29,311,495 61,951
2020-12-31 $28,104,440 58,174
2020-09-30 $27,566,925 49,246
2020-06-30 $27,987,540 44,877
2020-03-31 $18,256,185 37,388